Archivio per categoria: Pubblicazioni

, , , , , , , , , , , , ,

Evaluation of maintenance treatment with PARP inhibitors in ovarian carcinoma patients responding to platinum therapy: Use of restricted mean survival time as an index of efficacy.

Continua a leggere
, , , , , , , , , , , , , , , , , ,

Experience in managing independent clinical research, the best training strategy for future clinical pharmacists: the QOSMOS project

Continua a leggere
, , , , , , , , , , , , ,

Hospital pharmacy response to covid-19 pandemic in italy: what we learned from the first outbreak wave

Continua a leggere
, , , , , , , , , , , , ,

COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave.

Continua a leggere
, , , , , , , , , , , , , ,

Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital

Continua a leggere
, , , , , , , , , , ,

Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe.

Continua a leggere
, , , , , , , , , , , , , , , , , , , , ,

SARS-COV-2 pandemic: establishing three risk levels for 19 Italian regions and two autonomous provinces.

Continua a leggere
, , , , , , , , , , , ,

Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors.

Continua a leggere
, , , , , , , , , , ,

Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available.

Continua a leggere
, , , , , , , , , ,

The Restricted Mean Survival Time as a Tool for Ranking Comparative Outcomes in a Narrative Review that Evaluates a Network of Randomized Trials: An Example Based on PCSK9 Inhibitors

Continua a leggere